Search alternatives:
significantly linked » significantly longer (Expand Search), significantly altered (Expand Search), significantly higher (Expand Search)
linked decrease » marked decrease (Expand Search), linear decrease (Expand Search)
teer decrease » greater decrease (Expand Search)
Showing 261 - 280 results of 4,572 for search '(( significantly ((teer decrease) OR (mean decrease)) ) OR ( significantly linked decrease ))', query time: 0.46s Refine Results
  1. 261
    Demographic and Clinical Characteristics of Children Exposed or Not Exposed to the Fear Self-Assessment Tool (Trouillomètre®).

    Demographic and Clinical Characteristics of Children Exposed or Not Exposed to the Fear Self-Assessment Tool (Trouillomètre®). by Myriam Aïche (22290591)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 262
    Multivariate Linear Regression Analysis of Factors Associated with Pain Scores (VAS) in Children Aged 7–12.

    Multivariate Linear Regression Analysis of Factors Associated with Pain Scores (VAS) in Children Aged 7–12. by Myriam Aïche (22290591)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 263
    Flow chart.

    Flow chart. by Myriam Aïche (22290591)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 264
    Linear regression.

    Linear regression. by Myriam Aïche (22290591)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 265
    Comparison of Pain Scores (VAS) Between Children Exposed and Not Exposed to the Fear Self-Assessment Tool (Trouillomètre®).

    Comparison of Pain Scores (VAS) Between Children Exposed and Not Exposed to the Fear Self-Assessment Tool (Trouillomètre®). by Myriam Aïche (22290591)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 266
    Mean AIV-H9N2 shedding titer (Log<sub>10</sub>) in oropharyngeal swabs.

    Mean AIV-H9N2 shedding titer (Log<sub>10</sub>) in oropharyngeal swabs. by Oumayma Arbani (21001472)

    Published 2025
    Save to List
    Saved in:
  7. 267
    ECoG timescales decrease during spatial attention.

    ECoG timescales decrease during spatial attention. by Isabel Raposo (21615517)

    Published 2025
    “…Bottom: timescales significantly decrease during covert attention relative to the attend-out condition (two locations: <i>p</i> = 0.0244; four locations: <i>p</i> < 0.0001; mean ± SEM; whiskers indicate maximum and minimum; dots correspond to individual electrodes). …”
    Save to List
    Saved in:
  8. 268
    Summary of post-treatment disease course measures from MDMA-AT publications.

    Summary of post-treatment disease course measures from MDMA-AT publications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 269
    Study selection criteria.

    Study selection criteria. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 270
    Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications.

    Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 271
    Disease course measures after the PTSD treatments.

    Disease course measures after the PTSD treatments. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 272
    PICOS criteria for the SLR.

    PICOS criteria for the SLR. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 273
    Summary of post-treatment CAPS score changes from MDMA-AT publications.

    Summary of post-treatment CAPS score changes from MDMA-AT publications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 274
    Summary of post-treatment disease course measures from off-label medications clinical trials.

    Summary of post-treatment disease course measures from off-label medications clinical trials. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 275
    Summary of post-treatment CAPS score changes from clinical trials with psychotherapies.

    Summary of post-treatment CAPS score changes from clinical trials with psychotherapies. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 276
    Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes.

    Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 277
    Summary of post-treatment disease course measures from clinical trials with psychotherapies.

    Summary of post-treatment disease course measures from clinical trials with psychotherapies. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 278
    PRISMA flow chart.

    PRISMA flow chart. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 279
    Summary of clinical efficacy of relevant PTSD treatments.

    Summary of clinical efficacy of relevant PTSD treatments. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 280
    Post-treatment CAPS score changes from clinical trials with off-label PTSD medications.

    Post-treatment CAPS score changes from clinical trials with off-label PTSD medications. by Filip Stanicic (17808254)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: